247 related articles for article (PubMed ID: 23489559)
1. Tumor-associated macrophages in thoracic malignancies.
Lievense LA; Bezemer K; Aerts JG; Hegmans JP
Lung Cancer; 2013 Jun; 80(3):256-62. PubMed ID: 23489559
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of traditional Chinese medicine monomers on tumor-associated macrophages in non-small cell lung cancer.
Wan LQ; Tan Y; Jiang M; Hua Q
Chin J Nat Med; 2019 Oct; 17(10):729-737. PubMed ID: 31703753
[TBL] [Abstract][Full Text] [Related]
3. The Biological Role of Macrophage in Lung and Its Implications in Lung Cancer Immunotherapy.
Wang C; Gao Q; Wu J; Lu M; Wang J; Ma T
Adv Biol (Weinh); 2024 Jun; 8(6):e2400119. PubMed ID: 38684453
[TBL] [Abstract][Full Text] [Related]
4. Exercise, physical activity and breast cancer: the role of tumor-associated macrophages.
Goh J; Kirk EA; Lee SX; Ladiges WC
Exerc Immunol Rev; 2012; 18():158-76. PubMed ID: 22876727
[TBL] [Abstract][Full Text] [Related]
5. Role of tumor-associated macrophages in human malignancies: friend or foe?
Takeya M; Komohara Y
Pathol Int; 2016 Sep; 66(9):491-505. PubMed ID: 27444136
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma.
Minnema-Luiting J; Vroman H; Aerts J; Cornelissen R
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29601534
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis.
Mei J; Xiao Z; Guo C; Pu Q; Ma L; Liu C; Lin F; Liao H; You Z; Liu L
Oncotarget; 2016 Jun; 7(23):34217-28. PubMed ID: 27144518
[TBL] [Abstract][Full Text] [Related]
8. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
Gambardella V; Castillo J; Tarazona N; Gimeno-Valiente F; Martínez-Ciarpaglini C; Cabeza-Segura M; Roselló S; Roda D; Huerta M; Cervantes A; Fleitas T
Cancer Treat Rev; 2020 Jun; 86():102015. PubMed ID: 32248000
[TBL] [Abstract][Full Text] [Related]
9. A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting.
Sharifi L; Nowroozi MR; Amini E; Arami MK; Ayati M; Mohsenzadegan M
Int Immunopharmacol; 2019 Nov; 76():105880. PubMed ID: 31522016
[TBL] [Abstract][Full Text] [Related]
10. [Influence of tumor-associated macrophages on progression and prognosis of nasopharyngeal carcinoma].
Peng J; Ding T; Zheng LM; Shao JY
Ai Zheng; 2006 Nov; 25(11):1340-5. PubMed ID: 17094898
[TBL] [Abstract][Full Text] [Related]
11. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
[TBL] [Abstract][Full Text] [Related]
12. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
[TBL] [Abstract][Full Text] [Related]
13. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
[TBL] [Abstract][Full Text] [Related]
14. The influence of macrophages and the tumor microenvironment on natural killer cells.
Krneta T; Gillgrass A; Ashkar AA
Curr Mol Med; 2013 Jan; 13(1):68-79. PubMed ID: 22834841
[TBL] [Abstract][Full Text] [Related]
15. Using macrophage activation to augment immunotherapy of established tumours.
Fridlender ZG; Jassar A; Mishalian I; Wang LC; Kapoor V; Cheng G; Sun J; Singhal S; Levy L; Albelda SM
Br J Cancer; 2013 Apr; 108(6):1288-97. PubMed ID: 23481183
[TBL] [Abstract][Full Text] [Related]
16. The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies.
Zhu C; Kros JM; Cheng C; Mustafa D
Neuro Oncol; 2017 Oct; 19(11):1435-1446. PubMed ID: 28575312
[TBL] [Abstract][Full Text] [Related]
17. Role of tumor-associated macrophages in hematological malignancies.
Komohara Y; Niino D; Ohnishi K; Ohshima K; Takeya M
Pathol Int; 2015 Apr; 65(4):170-6. PubMed ID: 25707506
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for mesothelioma and lung cancer.
Vachani A; Moon E; Wakeam E; Albelda SM
Am J Respir Cell Mol Biol; 2010 Apr; 42(4):385-93. PubMed ID: 20160042
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer.
Tang X
Cancer Lett; 2013 May; 332(1):3-10. PubMed ID: 23348699
[TBL] [Abstract][Full Text] [Related]
20. Cancer-promoting tumor-associated macrophages: new vistas and open questions.
Mantovani A; Germano G; Marchesi F; Locatelli M; Biswas SK
Eur J Immunol; 2011 Sep; 41(9):2522-5. PubMed ID: 21952810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
